Tianjin Diabetes and Health Cohort Study
1 other identifier
observational
396,983
0 countries
N/A
Brief Summary
The goal of this observational study is to reveal the natural history of diabetes and the occurrence and development patterns of its complications, to evaluate the effectiveness of diabetes interventions, and to assess the health and medical burdens caused by diabetes in Tianjin, based on the medical records and health big data in Tianjin and correspondingly constructed diabetes-specific cohort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2009
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
March 29, 2025
CompletedFirst Posted
Study publicly available on registry
April 6, 2025
CompletedResults Posted
Study results publicly available
May 25, 2025
CompletedMay 25, 2025
May 1, 2025
16 years
March 29, 2025
April 10, 2025
May 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diabetes Complications
Diabetic Complications: diabetic retinopathy,diabetic nephropathy,cerebral infarction,coronary artery disease The diagnosis of coronary artery disease is based on a comprehensive assessment of the degree of coronary artery stenosis and evidence of myocardial ischemia, taking into account risk factors and clinical symptoms, and exclusion of other similar diseases. The diagnostic criteria for diabetic nephropathy are history of diabetes: clear and long history of diabetes, Urine protein test:Urinary microalbumin excretion rate (UACR) is a key indicator for early diagnosis, with a normal value of less than 30mg/g, 30-300m Diagnosis of diabetic retinopathy by fundus examination. Diagnostic criteria for cerebral infarction are ICD codes or the doctor's diagnosis. Data collection through chart review, patient self-reporting, imaging
Baseline and week 520
Secondary Outcomes (2)
Glycemic Control
baseline and week 520
Death
baseline and week 520
Interventions
Eligibility Criteria
This study was conducted through the University-Enterprise Joint Laboratory for Diabetes Epidemiology Research at Tianjin Medical University, China. Longitudinal multi-source health big data from 2009 to 2024 (encompassing 396,983 individuals with diabetes treated in secondary and tertiary healthcare facilities in Tianjin) were integrated to establish a representative diabetes population cohort.
You may qualify if:
- Patients diagnosed with diabetes
- Patients with three or more recorded visits
- The following information was complete at the first visit: age, sex, Blood Glucoseor ,glycated hemoglobin(HbA1c)
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Zhenqiang Song, M.S., Associate Professor and Master's Supervisor
- Organization
- Tianjin Medical University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Researcher,Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University
Study Record Dates
First Submitted
March 29, 2025
First Posted
April 6, 2025
Study Start
January 1, 2009
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
May 25, 2025
Results First Posted
May 25, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Access to raw datasets is restricted under legally binding agreements with the collaborating institutions, as these prohibit data sharing with third parties. However, de-identified aggregate findings, statistical summaries, or the study protocol can be made available upon reasonable request to the Principal Investigator (PI).